Epilepsia Open® Most Cited Articles
Epilepsia Open’s Most-Cited Articles by Publication Year
Explore the Epilepsia Open articles that have generated the greatest impact in the scientific community. These highly cited works continue to inform research, guide clinical decisions, and advance understanding of epilepsy worldwide.
2025 (articles published in 2024-2025)
Myoclonus: Differential diagnosis and current management
Refining management strategies for Lennox-Gastaut syndrome: Updated algorithms and practical approaches
Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain
Pediatric neuromodulation for drug-resistant epilepsy: Survey of current practices, techniques, and outcomes across US epilepsy centers
The cenobamate KORK study-A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add-on lacosamide, perampanel, and brivaracetam
Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures
Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: A network meta-analysis
Consensus panel recommendations for the optimization of EPIDIOLEX treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
Stereo-electroencephalography-guided three-dimensional radiofrequency thermocoagulation for mesial temporal lobe epilepsy with hippocampal sclerosis: A retrospective study with long-term follow-up
Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review
2024
The cenobamate KORK study-A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add-on lacosamide, perampanel, and brivaracetam
Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: A network meta-analysis
Stereo-electroencephalography-guided three-dimensional radiofrequency thermocoagulation for mesial temporal lobe epilepsy with hippocampal sclerosis: A retrospective study with long-term follow-up
Pediatric neuromodulation for drug-resistant epilepsy: Survey of current practices, techniques, and outcomes across US epilepsy centers
Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain
Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1 related epilepsy: A systematic review
Myoclonus: Differential diagnosis and current management
Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures
Norwegian population-based study of effectiveness of vagus nerve stimulation in patients with developmental and epileptic encephalopathies
Refining management strategies for Lennox-Gastaut syndrome: Updated algorithms and practical approaches
2023
Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
EEG datasets for seizure detection and prediction- A review
Dravet syndrome: A systematic literature review of the illness burden
Real-world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study
Sudden unexpected death in epilepsy: A critical view of the literature
Status of epilepsy in the tropics: An overlooked perspective
Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations
Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India
Epilepsy surgery in early infancy: A retrospective, multicenter study
Antiepileptogenesis after stroke-trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate